Tuesday, January 6, 2026

Traumatic Brain Injury in the Era of Precision Neurology: What Clinicians Need to Know

Traumatic Brain Injury (TBI) continues to be one of the most complex and impactful challenges in modern neurology, affecting millions globally and remaining a leading cause of long-term disability. At the International Conference on Neurology and Neuroscience 2026, a compelling Keynote Presentation will be delivered by Jonathan Eskenazi, Clinical Assistant Professor at UCLA School of Medicine, United States, focusing on the theme “Traumatic Brain Injury: What’s New?”

This keynote brings together cutting-edge science and real-world clinical practice, highlighting how neurotrauma care is rapidly transitioning from traditional symptom-based protocols to precision-driven, biomarker-informed management.

🔍 Key Insights from the Presentation

  • Modern Understanding of TBI
    Updated definitions and classification of TBI—mild, moderate, and severe—emphasizing functional impact, symptom burden, and recovery trajectories rather than injury mechanism alone.

  • Breakthroughs in Early Diagnosis
    Introduction of FDA-cleared blood biomarkers GFAP and UCH-L1, now available in whole-blood and automated formats, allowing rapid emergency department triage and safer reduction of unnecessary CT imaging.

  • Transforming Mild TBI (mTBI) Care
    Evidence shows GFAP levels can rise within 30 minutes of injury, enabling ultra-early detection and moving care beyond the outdated “rest and discharge” approach toward risk-stratified follow-up.

  • Evolving ICU Strategies
    Growing preference for hypertonic saline over mannitol in managing intracranial pressure crises, alongside insights from the NIH BOOST-3 trial, which evaluates combined intracranial pressure and brain oxygen monitoring.

  • Personalized Neurotrauma Pathways
    Data from international collaborations such as CENTER-TBI and TRACK-TBI demonstrate how genetics, mental health, and social factors influence recovery, supporting individualized rehabilitation and long-term care planning.

  • Prevention as a Clinical Priority
    Reinforcement of evidence-based prevention strategies including helmet use, seatbelts, and fall-prevention programs for older adults.

👨‍⚕️ Speaker Profile

Jonathan Eskenazi, MD, is a Double Board-Certified Neurologist with advanced expertise in traumatic brain injury, vascular neurology, and neurocognitive disorders. He serves as a Clinical Neurology Attending at Cedars-Sinai and has played a pivotal role in developing acute neurology programs across major medical centers in Los Angeles.

Dr. Eskenazi’s clinical scope spans neurotrauma, stroke, epilepsy, multiple sclerosis, brain tumors, sleep disorders, and movement disorders, with specialized skills in neurostimulation for Parkinson’s disease, EEG interpretation, vestibular disorders, and therapeutic botulinum toxin applications for migraine and spasticity.

🌐 Why This Session Stands Out

This keynote underscores a defining shift in neuroscience—from generalized treatment algorithms to biomarker-guided, multimodal, and patient-specific neurotrauma care. It offers clinicians, researchers, and allied professionals practical insights that directly translate into improved outcomes and long-term recovery for TBI patients.

📌 Event Details

#TraumaticBrainInjury #PrecisionNeurology #NeurotraumaCare #NeurologyConference #BrainBiomarkers #mTBI #GFAP #UCHL1 #NeuroscienceResearch #NeuroCriticalCare #BrainHealth #Singapore2026

at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)